Primary Central Nervous System Lymphoma in Immunocompetent Adults: Poor Results Mainly Associated with High Treatment Related Toxicities
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 43 (9) , 1819-1822
Abstract
Treatment of primary central nervous system lymphoma (PCNSL) occurring in immunocompetent patients remains controversial but long-term survival has been reported in patients treated by chemotherapy regimens containing non-lipophilic drugs. We report 34 consecutive PCNSL patients treated at our institution by a chemotherapy regimen that combined drugs crossing and not crossing the blood-brain barrier. Early toxicity was high as 10 of 17 deaths that occurred within the first year of diagnosis were treatment related. Infections and thromboembolism were the main causes of toxicity. We concluded that the use of drugs of uncertain efficacy in these particularly fragile patients is questionable.Keywords
This publication has 12 references indexed in Scilit:
- Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftmentNature Medicine, 2001
- Anti-CD20 Monoclonal Antibody (Rituximab) and Cidofovir as Successful Treatment of an EBV-Associated Lymphoma with CNS InvolvementOncology Research and Treatment, 2001
- High Concentration of Daunorubicin and Daunorubicinol in Human Malignant Astrocytomas after Systemic Administration of Liposomal DaunorubicinJournal of Neuro-Oncology, 2001
- Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell LymphomaLeukemia & Lymphoma, 2001
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- Successful Treatment of Aggressive Post Transplant Lymphoproliferative Disorder using RituximabLeukemia & Lymphoma, 2000
- Primary CNS Lymphoma: Treatment with Combined Chemotherapy and RadiotherapyJournal of Neuro-Oncology, 1999
- Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.Journal of Clinical Oncology, 1998
- Curative Potential of Herpes Simplex Virus Thymidine Kinase Gene Transfer in Rats with 9L GliosarcomaHuman Gene Therapy, 1996